237 related articles for article (PubMed ID: 18470646)
1. Reducing the genotoxic potential of retroviral vectors.
Ramezani A; Hawley TS; Hawley RG
Methods Mol Biol; 2008; 434():183-203. PubMed ID: 18470646
[TBL] [Abstract][Full Text] [Related]
2. Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells.
Bosticardo M; Ghosh A; Du Y; Jenkins NA; Copeland NG; Candotti F
Mol Ther; 2009 Nov; 17(11):1910-8. PubMed ID: 19638958
[TBL] [Abstract][Full Text] [Related]
3. Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors.
Schambach A; Galla M; Maetzig T; Loew R; Baum C
Mol Ther; 2007 Jun; 15(6):1167-73. PubMed ID: 17406345
[TBL] [Abstract][Full Text] [Related]
4. Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity.
Modlich U; Bohne J; Schmidt M; von Kalle C; Knöss S; Schambach A; Baum C
Blood; 2006 Oct; 108(8):2545-53. PubMed ID: 16825499
[TBL] [Abstract][Full Text] [Related]
5. Physiological promoters reduce the genotoxic risk of integrating gene vectors.
Zychlinski D; Schambach A; Modlich U; Maetzig T; Meyer J; Grassman E; Mishra A; Baum C
Mol Ther; 2008 Apr; 16(4):718-25. PubMed ID: 18334985
[TBL] [Abstract][Full Text] [Related]
6. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
7. Retroviral Insertional Mutagenesis in Humans: Evidence for Four Genetic Mechanisms Promoting Expansion of Cell Clones.
Bushman FD
Mol Ther; 2020 Feb; 28(2):352-356. PubMed ID: 31951833
[TBL] [Abstract][Full Text] [Related]
8. Deletion of a negatively acting sequence in a chimeric GATA-1 enhancer-long terminal repeat greatly increases retrovirally mediated erythroid expression.
Testa A; Lotti F; Cairns L; Grande A; Ottolenghi S; Ferrari G; Ronchi A
J Biol Chem; 2004 Mar; 279(11):10523-31. PubMed ID: 14701820
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity of retroviral integration in hematopoietic cells.
Nienhuis AW; Dunbar CE; Sorrentino BP
Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design.
Maruggi G; Porcellini S; Facchini G; Perna SK; Cattoglio C; Sartori D; Ambrosi A; Schambach A; Baum C; Bonini C; Bovolenta C; Mavilio F; Recchia A
Mol Ther; 2009 May; 17(5):851-6. PubMed ID: 19293778
[TBL] [Abstract][Full Text] [Related]
11. Establishment of modified retroviral vector targeting X-linked severe combined immunodeficiency.
Zhi CL; Migita M; Hayakawa J; Fukunaga Y
J Nippon Med Sch; 2004 Feb; 71(1):51-6. PubMed ID: 15129596
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vectors: post entry events and genomic alterations.
Nowrouzi A; Glimm H; von Kalle C; Schmidt M
Viruses; 2011 May; 3(5):429-55. PubMed ID: 21994741
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.
Espinoza DA; Fan X; Yang D; Cordes SF; Truitt LL; Calvo KR; Yabe IM; Demirci S; Hope KJ; Hong SG; Krouse A; Metzger M; Bonifacino A; Lu R; Uchida N; Tisdale JF; Wu X; DeRavin SS; Malech HL; Donahue RE; Wu C; Dunbar CE
Mol Ther; 2019 Jun; 27(6):1074-1086. PubMed ID: 31023523
[TBL] [Abstract][Full Text] [Related]
14. Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity.
Richardson TB; Kaspers J; Porter CD
Gene Ther; 2004 May; 11(9):775-83. PubMed ID: 14999228
[TBL] [Abstract][Full Text] [Related]
15. Liver-directed gene therapy: a retroviral vector with a complete LTR and the ApoE enhancer-alpha 1-antitrypsin promoter dramatically increases expression of human alpha 1-antitrypsin in vivo.
Okuyama T; Huber RM; Bowling W; Pearline R; Kennedy SC; Flye MW; Ponder KP
Hum Gene Ther; 1996 Mar; 7(5):637-45. PubMed ID: 8845389
[TBL] [Abstract][Full Text] [Related]
16. Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors.
Yannaki E; Tubb J; Aker M; Stamatoyannopoulos G; Emery DW
Mol Ther; 2002 May; 5(5 Pt 1):589-98. PubMed ID: 11991750
[TBL] [Abstract][Full Text] [Related]
17. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
Kaneko S; Onodera M; Fujiki Y; Nagasawa T; Nakauchi H
Hum Gene Ther; 2001 Jan; 12(1):35-44. PubMed ID: 11177540
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells.
Grande A; Piovani B; Aiuti A; Ottolenghi S; Mavilio F; Ferrari G
Blood; 1999 May; 93(10):3276-85. PubMed ID: 10233879
[TBL] [Abstract][Full Text] [Related]
19. Novel principles of gamma-retroviral insertional transcription activation in murine leukemia virus-induced end-stage tumors.
Sokol M; Wabl M; Ruiz IR; Pedersen FS
Retrovirology; 2014 May; 11():36. PubMed ID: 24886479
[TBL] [Abstract][Full Text] [Related]
20. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
